Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study

Dyskinesia and Pain in Advanced Parkinson’s Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study

Abstract Introduction The DYSCOVER study was a phase 3b, open-label, randomized trial (NCT02799381) that evaluated levodopa-carbidopa intestinal gel (LCIG) versus optimized medical treatment (OMT) in patients with Parkinson’s disease (PD) and a high burden of dyskinesia at baseline (defined as Unifi...

Full description

Bibliographic Details
Main Authors: Eric Freire-Alvarez, Paola Vanni, Egon Kurča, Lydia Lopez-Manzanares, Norbert Kovács, Cleanthe Spanaki, Tianming Gao, Lars Bergmann, Olga Sánchez-Soliño
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-02-01
Series:Neurology and Therapy
Subjects:
Dyskinesias
Levodopa-carbidopa intestinal gel
Pain
Parkinson’s disease
Quality of life
Online Access:https://doi.org/10.1007/s40120-024-00583-z

Internet

https://doi.org/10.1007/s40120-024-00583-z

Similar Items